tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Orthocell Ltd Announces Proposed Securities Issue to Boost Capital

Story Highlights
Orthocell Ltd Announces Proposed Securities Issue to Boost Capital

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Orthocell Ltd ( (AU:OCC) ) has provided an announcement.

Orthocell Ltd announced a proposed issue of securities, including options expiring in 2028 and 2029, as part of a placement or other type of issue. This move is likely to impact the company’s financial strategy and market positioning by potentially increasing its capital base, which could be used to further its research and development efforts in regenerative medicine.

The most recent analyst rating on (AU:OCC) stock is a Buy with a A$1.32 price target. To see the full list of analyst forecasts on Orthocell Ltd stock, see the AU:OCC Stock Forecast page.

More about Orthocell Ltd

Orthocell Ltd operates in the biotechnology industry, focusing on regenerative medicine. The company is known for developing and commercializing cell therapies and collagen medical devices aimed at repairing and regenerating soft tissue injuries.

Average Trading Volume: 883,671

Technical Sentiment Signal: Strong Buy

Current Market Cap: A$325.6M

See more insights into OCC stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1